Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, No.95 Yongan Road, Xicheng District, Beijing, China.
Department of Radiology, Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin, Heilongjiang Province, China.
BMC Cancer. 2021 Mar 9;21(1):258. doi: 10.1186/s12885-021-07944-z.
The aim of this study was to investigate the relationship between multiple metabolism parameters derived from FDG and tumor TNM stages as well as tumor metastasis-associated protein of GLUT-1 and MACC1 in colorectal carcinoma (CRC).
Thirty-eight patients (24 males and 14 females) with primary CRC confirmed by elective surgery pathological, who also accepted F-FDG PET/CT scans during 2017 to 2019 were included in this study. The tumor classification of T, N and M is explained by the 7th American Joint Committee on Cancer (AJCC). F-FDG parameters of SUVmax, SUVmean, TLG and MTV were measured by drawing a region of interest on the primary lesions. The expression of GLUT-1 and MACC1 was quantified by immunohistochemical, and the correlation between metabolism parameters and tumor biomarkers were analyzed.
According to our analysis, the F-FDG parameters of SUVmean was significantly correlated with tumor M status (P = 0.000) of primary CRC. The primary tumor lesion with higher SUVmax, TLG and MTV values prone to a high-T status (P = 0.002, 0.002 and 0.001, respectively). The high expression of GLUT-1/MACC1 weas more frequently involved with T3-4 stage and was poorly differentiated in CRC patients. Multivariate analysis found that the expression of GLUT-1 protein was correlated with SUVmax and MTV (R = 0.42, P = 0.013 and 0.004, respectively), moreover, the expression of MACC1 protein was correlated with TLG (R = 0.372, P = 0.000).
Glucose metabolism parameters derived from FDG provides a noninvasive assessment of M status and T status in CRC patients. The expression of GLUT-1 and MACC1 was associated with F-FDG uptake in CRC patients.
本研究旨在探讨来源于 FDG 的多个代谢参数与结直肠癌(CRC)的肿瘤 TNM 分期以及肿瘤转移相关蛋白 GLUT-1 和 MACC1 之间的关系。
本研究纳入了 2017 年至 2019 年期间因原发性 CRC 接受择期手术病理证实并接受 F-FDG PET/CT 扫描的 38 例患者(24 名男性和 14 名女性)。T、N 和 M 的肿瘤分类由第 7 版美国癌症联合委员会(AJCC)解释。通过在原发性病变上绘制感兴趣区域来测量 SUVmax、SUVmean、TLG 和 MTV 等 F-FDG 参数。通过免疫组织化学定量检测 GLUT-1 和 MACC1 的表达,并分析代谢参数与肿瘤标志物之间的相关性。
根据我们的分析,原发性 CRC 肿瘤 M 状态与 F-FDG 参数 SUVmean 显著相关(P=0.000)。SUVmax、TLG 和 MTV 值较高的原发性肿瘤病变更易出现高 T 状态(P=0.002、0.002 和 0.001)。CRC 患者中 GLUT-1/MACC1 的高表达更频繁地涉及 T3-4 期和低分化。多变量分析发现,GLUT-1 蛋白的表达与 SUVmax 和 MTV 相关(R=0.42,P=0.013 和 0.004),此外,MACC1 蛋白的表达与 TLG 相关(R=0.372,P=0.000)。
来源于 FDG 的葡萄糖代谢参数为 CRC 患者的 M 状态和 T 状态提供了一种非侵入性评估。GLUT-1 和 MACC1 的表达与 CRC 患者的 F-FDG 摄取有关。